HawkInsight

  • Contact Us
  • App
  • English

<IPO>CN Biotech Firm InxMed Submits Application for HK IPO

HKEX (00388.HK) disclosed that InxMed submitted a listing application to HKEX. CITIC Securities a...

HKEX (00388.HK) disclosed that InxMed submitted a listing application to HKEX. CITIC Securities and CCBI are its joint sponsors.

InxMed is a Chinese biotech company focused on cancer treatment, addressing the issue of tumor drug resistance.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-09-08 16:25.)

Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.